Claudia Hesselmann, chemist by training with PhD in molecular biology, has over 15 years of expertise in the early phases of drug development. This includes co-founding and holding management positions in various CROs with activities in Western and Eastern Europe, Japan and Middle East. With such extensive experience and based on long-time networking in the

Pharmaceutical industry, Claudia has co-founded ARENSIA Exploratory Medicine in Düsseldorf, Germany, with the purpose of contributing with innovative strategies to the acceleration of the drug development process. ARENSIA runs its own network of modern Phase I units, located in large hospitals in Eastern Europe. The units are specialized to perform sophisticated Phase Ib/IIa/Proof-of-Concept trials in PATIENTS, with extraordinary recruitment speed across most therapeutic areas.